Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Veracyte Inc
Veracyte Inc logo

VCYT - Veracyte Inc Share News

$46.91 -8.5  -15.3%

Last Trade - 04/03/21

Sector
Healthcare
RiskRating
Adventurous
Size
Mid Cap
Style
Style Neutral
Market Cap £2.26bn
Enterprise Value £2.01bn
Revenue £84.6m
Position in Universe 1752nd / 6647
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions VCYT Dividends
All News
All News Reuters News Company Announcements
BRIEF-Veracyte Q1 Loss Per Share $0.27
1st May '18 News
BRIEF-Veracyte Announces Precision Medicine Collaboration With Loxo Oncology
11th Apr '18 News
BRIEF-Veracyte Inc Q4 Net Loss Per Common Share $0.24
27th Feb '18 News
BRIEF-Veracyte Announces Strategic Realignment And New Appointments To Advance Commercial Growth
8th Jan '18 News
BRIEF-Veracyte posts Q3 loss per share $0.21
6th Nov '17 News
BRIEF-Veracyte announces release of 2018 preliminary reimbursement rate for Afirma Genomic Classifier under PAMA
25th Sep '17 News
BRIEF-Veracyte reports Q2 loss per share $0.22
31st Jul '17 News
BRIEF-Veracyte announces pivotal clinical validation data
4th May '17 News
BRIEF-Veracyte announces Q1 revenue $16.4 million
3rd May '17 News
BRIEF-Veracyte reports qtrly loss per share $0.14
1st Mar '17 News
BRIEF-Veracyte names Christopher Hall as COO
28th Feb '17 News
BRIEF-Veracyte to expand patient access to the Afirma gene expression classifier in thyroid cancer diagnosis
8th Feb '17 News
BRIEF-Veracyte says Palmetto GBA has finalized coverage policy for percepta bronchial genomic classifier
6th Feb '17 News
BRIEF-Veracyte says CMS has determined Afirma gene expression classifier's current rate will be maintained in 2017
22nd Nov '16 News
BRIEF-Veracyte appoints Keith Kennedy as chief financial officer
21st Nov '16 News
BRIEF-Broadfin Capital Llc reports 5.8 pct passive stake in Veracyte Inc
4th Nov '16 News
BRIEF-Veracyte announces third quarter 2016 financial results
3rd Nov '16 News
BRIEF-Veracyte prices public offering of 5 mln shares of common stock
2nd Nov '16 News
BRIEF-Veracyte announces launch of Envisia Genomic Classifier
25th Oct '16 News
BRIEF-Veracyte releases statement on CMS's final 2017 gapfill rate for afirma gene expression classifier
1st Oct '16 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.